Clinical Trial Update: Erlotinib,Radiation and Cisplatin in Patients With Complete Resected Squamous Cell Carcinoma of the Head and Neck [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating erlotinib with radiation and cisplatin in patients with completely resected squamous cell carcinoma of the head and neck has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• ERLOTINIB (Erlotinib)

Snippet

Sponsor: Grupo de Investigación Clínica en Oncología Radioterapia | Conditions: Squamous Cell Carcinoma of the Head and Neck | Phase 3 | Status: COMPLETED